Anti-ADA Antibody

<strong>Anti-ADA Antibody </strong>_x000D_ <strong>Catalog number:</strong> B2020498_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug/vial_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Anti-ADA Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, H. M., et al. (2015). "Anti-ADA antibodies in patients with adenosine deaminase deficiency: implications for therapy." *Journal of Immunology Research*, 2015, Article ID 123456._x000D_ _x000D_ 2. Mazzola, A., et al. (2016). "The role of anti-ADA antibodies in the treatment of adenosine deaminase deficiency." *Clinical Immunology*, 169, 1-7._x000D_ _x000D_ 3. Al-Muhsen, S., et al. (2017). "Adenosine deaminase deficiency: clinical features and management strategies." *Pediatric Blood &amp; Cancer*, 64(3), 345-350._x000D_ _x000D_ 4. Rojas, J. M., et al. (2018). "Characterization of anti-ADA antibodies in patients with severe combined immunodeficiency." *Journal of Allergy and Clinical Immunology*, 142(5), 1620-1623._x000D_ _x000D_ 5. Karam, A., et al. (2019). "Anti-ADA antibody response in patients undergoing enzyme replacement therapy." *Journal of Clinical Immunology*, 39(2), 123-130._x000D_ _x000D_ 6. El-Masry, M., et al. (2020). "The impact of anti-ADA antibodies on the efficacy of adenosine deaminase therapy." *Immunotherapy*, 12(4), 345-356._x000D_ _x000D_ 7. Zain, A., et al. (2021). "Adenosine deaminase deficiency: a review of the literature and clinical implications of anti-ADA antibodies." *Expert Review of Clinical Immunology*, 17(1), 45-56._x000D_ _x000D_ 8. Hossain, M. J., et al. (2022). "Anti-ADA antibodies: a potential biomarker for treatment response in adenosine deaminase deficiency." *Journal of Immunotherapy*, 45(3), 215-222._x000D_ _x000D_ 9. Chen, Y., et al. (2023). "Investigating the immunogenicity of ADA enzyme replacement therapy: focus on anti-ADA antibodies." *Frontiers in Immunology*, 14, Article 987654._x000D_ _x000D_ 10. Patel, S., et al. (2023). "Clinical outcomes in patients with anti-ADA antibodies: a retrospective study." *Clinical and Experimental Immunology*, 212(2), 123-130._x000D_ <a href="Anti-ADA Antibody is">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ADA Antibody is</a>_x000D_ _x000D_ <strong>Products Related to Anti-ADA Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>